Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SIAIS178 is a potent and selective degrader of BCR-ABL based on PROTAC technology (IC50 of 24 nM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,650 | 待询 | ||
5 mg | ¥ 3,990 | 待询 | ||
10 mg | ¥ 5,410 | 待询 | ||
50 mg | ¥ 16,200 | 待询 | ||
100 mg | ¥ 22,800 | 待询 | ||
200 mg | 待询 | 待询 | ||
500 mg | 待询 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 4,390 | 待询 |
产品描述 | SIAIS178 is a potent and selective degrader of BCR-ABL based on PROTAC technology (IC50 of 24 nM). |
靶点活性 | VHL:24 nM, BCR-ABL:24 nM |
体外活性 | the BCR-ABL protein levels in a concentration dependent manner significantly reduced by SIAIS178 (1-100 nM; for 16 hours) . SIAIS178 significantly inhibits the phosphorylation of BCR-ABL and the substrates STAT5. in BCR-ABL driven CML cell lines, SIAIS178 (1, 10, 100, 1000 nM) exerts significant antiproliferative activity. SIAIS178 retains potency and selectivity against the BCR-ABL driven cell lines. |
体内活性 | Tumor progression in a dose-dependent manner attenuated by SIAIS178 (ip; 5, 15, and 45 mg/kg; 12 days), as determined by serial volumetric measurement . SIAIS178 (iv or ip; 2 mg/kg; 24 hours) has T1/2 of 3.82 and 12.35 hours and Cmax of 1165.2 nM and 30 nM for iv and ip, respectively. |
分子量 | 1012.68 |
分子式 | C50H62ClN11O6S2 |
CAS No. | 2376047-73-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 300 mg/mL (296.24 mM), Sonification is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 0.9875 mL | 4.9374 mL | 9.8748 mL | 24.687 mL |
5 mM | 0.1975 mL | 0.9875 mL | 1.975 mL | 4.9374 mL | |
10 mM | 0.0987 mL | 0.4937 mL | 0.9875 mL | 2.4687 mL | |
20 mM | 0.0494 mL | 0.2469 mL | 0.4937 mL | 1.2343 mL | |
50 mM | 0.0197 mL | 0.0987 mL | 0.1975 mL | 0.4937 mL | |
100 mM | 0.0099 mL | 0.0494 mL | 0.0987 mL | 0.2469 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SIAIS178 2376047-73-1 Angiogenesis Cytoskeletal Signaling Others Tyrosine Kinase/Adaptors Bcr-Abl SIAIS 178 SIAIS-178 Inhibitor inhibitor inhibit